Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing the proprietary RNA interference platform.

Biotechnology

Education

Atalanta Therapeutics

Atalanta Therapeutics' headquarters in Boston, MA, United States

Guillermo Yudowski

Mingwei Li

Michele Keough

Craig Mello

Jeff Young

Serena Hung

Garth Kinberger

Stefan McDonough

Antonio N.

Qingmin Chen

Stephen Burke

Caroline Kostyla

Mark Murphy

Edward English

Brittany Ferdman

Corrie Gallant-Behm

Megan Leader

Benjamin Andreone

Jim Glasheen

Neil Aronin

T. Scott Johnson

Stacie Weninger

Anastasia Khvorova

Michael Berman

Stephen Knight

Alfred W. Sandrock

The Scientific Research Team at Atalanta Therapeutics conducts cutting-edge research to advance the development of RNA interference therapies for neurodegenerative diseases. By employing a diverse range of scientific expertise—from assay development to molecular biology—the team works collaboratively to identify and validate novel therapeutic targets, optimize RNA-based treatments, and support preclinical studies for innovative drug candidates.

Scientific Research Team

The Research and Development team at Atalanta Therapeutics focuses on advancing innovative therapies for neurodegenerative diseases through cutting-edge research in RNA interference. Comprising experts in biochemistry, pharmacology, chemistry, and neuroscience, the team collaborates to design, test, and refine novel drug candidates, ensuring they meet the rigorous standards needed for clinical development. Their ultimate goal is to translate scientific discoveries into effective treatments that improve patient outcomes.

Research and Development

The Scientific and Technical Advisory team at Atalanta Therapeutics provides expert guidance and strategic oversight on the development of innovative RNA interference therapies targeting neurodegenerative diseases. Comprising experienced co-founders and directors, this team collaborates to assess scientific advancements, shape research directions, and ensure alignment with the company’s mission to deliver effective treatment options.

Scientific and Technical Advisory

The Leadership Team at Atalanta Therapeutics is responsible for guiding the company's strategic direction and overseeing the development of innovative therapies for neurodegenerative diseases. Composed of experts in scientific research, corporate development, and human resources, the team collaborates to drive the research and commercialization of the proprietary RNA interference platform, ensuring alignment between scientific goals and business objectives.

Leadership Team

The Operations Team at Atalanta Therapeutics plays a crucial role in ensuring the seamless execution of day-to-day activities across various functions. This team oversees supply chain management, facilities maintenance, and laboratory operations to support the development of innovative therapies for neurodegenerative diseases. By coordinating resources, managing projects, and optimizing workflows, the Operations Team enables the organization to advance its mission efficiently and effectively.

Operations Team

This department manages and oversees the planning and execution of clinical operations and development projects.

Clinical Operations

��

Atalanta Therapeutics

Org chart

Board & advisors

Teams

Scientific Research Team

Research and Development

Scientific and Technical Advisory

Leadership Team

Operations Team

Clinical Operations

Offices

��������

Atalanta Therapeutics

Org chart

Board & advisors

Teams

Scientific Research Team

Research and Development

Scientific and Technical Advisory

Leadership Team

Operations Team

Clinical Operations

Offices

Related companies

��